OpenAI researcher Miles Wang is leaving the ChatGPT developer to start an AI company aimed at drug development. Many OpenAI researchers are also expected to join this new project. Currently, Miles Wang is negotiating about $200 million in financing at a valuation of $2 billion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.